These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9259679)

  • 1. The CAPTURE trial.
    Umans VA; Kloeg PH; Bronzwaer J
    Lancet; 1997 Aug; 350(9075):445. PubMed ID: 9259679
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous revascularization for unstable angina in the elderly.
    Hirsch H; Lazar J; Marzo KP; Steingart RM
    Coron Artery Dis; 2000 Jun; 11(4):315-22. PubMed ID: 10860174
    [No Abstract]   [Full Text] [Related]  

  • 3. Different benefits, different risks, equal cost.
    Colombo A
    Eur Heart J; 1999 Nov; 20(21):1531-2. PubMed ID: 10529320
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glycoprotein IIb/IIIa antagonists].
    Hennemann A
    Med Monatsschr Pharm; 2000 Dec; 23(12):385-90. PubMed ID: 11147193
    [No Abstract]   [Full Text] [Related]  

  • 5. Microvascular obstruction in acute coronary syndromes: onward to a new therapeutic target.
    Schwartz RS
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):170-2. PubMed ID: 16142803
    [No Abstract]   [Full Text] [Related]  

  • 6. Abciximab, a novel platelet-blocking drug: pharmacology and nursing implications.
    Mayer DM; Docktor WJ
    Crit Care Nurse; 1998 Apr; 18(2):29-37. PubMed ID: 9708118
    [No Abstract]   [Full Text] [Related]  

  • 7. Low molecular weight heparins in the cardiac catheterization laboratory.
    Montalescot G; Cohen M
    J Thromb Thrombolysis; 1999 Jun; 7(3):319-23. PubMed ID: 10373715
    [No Abstract]   [Full Text] [Related]  

  • 8. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
    Popma JJ; Satler LF
    J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy for ischemic heart disease.
    Lange RA; Hillis LD
    N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?
    Di Sciascio G; Mangiacapra F
    J Am Coll Cardiol; 2012 Jul; 60(5):378-80. PubMed ID: 22682552
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intervention therapy of acute coronary syndrome].
    Yamaguchi T; Nakamura M; Mitsuo K; Matsuda K
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1742-8. PubMed ID: 10581757
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].
    Obradović S; Gligić B; Djordjević D; Jovicić A; Romanović R; Ratković N; Dincić D; Orozović V; Nikolić G
    Vojnosanit Pregl; 2001; 58(1):65-72. PubMed ID: 11419288
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of differing pharmacologic strategies on infarct size in primary PCI--more confirmatory data for bivalirudin.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1090-1. PubMed ID: 22674760
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial.
    van den Brand M; Laarman GJ; Steg PG; De Scheerder I; Heyndrickx G; Beatt K; Kootstra J; Simoons ML
    Eur Heart J; 1999 Nov; 20(21):1572-8. PubMed ID: 10529325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two new antiplatelet drugs for angioplasty and acute coronary syndromes.
    Med Lett Drugs Ther; 1998 Sep; 40(1035):89-90. PubMed ID: 9760948
    [No Abstract]   [Full Text] [Related]  

  • 16. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
    Mehta SR;
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. An industry perspective on health economics studies.
    Anderson KM; Bala MV; Weisman HF
    Am Heart J; 1999 May; 137(5):S129-32. PubMed ID: 10220615
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of unstable angina pectoris. Thrombocyte aggregation inhibition improves chances for survival].
    Z Kardiol; 1998 Aug; 87(8 Suppl Thrombozy):1-3. PubMed ID: 9789356
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of acute coronary syndromes.
    Schulman SP; Fessler HE
    Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined use of Orgaran and Reopro during coronary angioplasty in patients unable to receive heparin.
    Cantor WJ; Leblanc K; Garvey B; Watson KR; Rasymas A; Strauss BH
    Catheter Cardiovasc Interv; 1999 Mar; 46(3):352-5. PubMed ID: 10348139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.